Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Aasiya Matin"'
Autor:
Yun Wang, Ran Reshef, Gavin MacBeath, Jim Murray, Debora Barton, Erica Buonomo, Shrikanta Chattopadhyay, Monzr Al Malki, Alla Keyzner, Hyung C Suh, Aasiya Matin, Nina Abelowitz
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/b66bbc9339274a27a90f5fd7a529a27b
Autor:
Aung M. Tun, Yucai Wang, Aasiya Matin, David J. Inwards, Thomas M. Habermann, Ivana Micallef, Patrick B. Johnston, Luis Porrata, Jonas Paludo, Jose Villasboas Bisneto, Allison Rosenthal, Han W. Tun, James R. Cerhan, Thomas E. Witzig, Grzegorz S. Nowakowski, Stephen M. Ansell
Publikováno v:
HemaSphere, Vol 7, Iss 4, p e869 (2023)
Immune checkpoint inhibitors (ICIs) and brentuximab vedotin (BV) are novel agents for classic Hodgkin lymphoma, including relapse after autologous stem cell transplant (ASCT). However, their impact on survival post-ASCT relapse, in comparison with co
Externí odkaz:
https://doaj.org/article/a4ab29ec31e74a8da4ff4f0b41f86131
Autor:
Pankaj Mathur, Blake Hollowoa, Nupur Lala, Sharmilan Thanendrarajan, Aasiya Matin, Atul Kothari, Carolina Schinke
Publikováno v:
Hematology Reports, Vol 9, Iss 3 (2017)
Autologous hematopoietic stem cell transplant (AHSCT) is the standard of care in the treatment of multiple myeloma worldwide. Infections are one of the most common complications of the chemotherapy regimen and AHSCT. Thrombotic microangiopathies are
Externí odkaz:
https://doaj.org/article/bc6456c83a4f4fe783d12d18e1a68da2
Autor:
Aasiya Matin, Byron H. Smith, Abhishek Mangaonkar, Dustin J. Duffy, Robert Wolf, Hassan Alkhateeb, Mithun V. Shah, William J. Hogan, Mark R. Litzow
Publikováno v:
Transplantation and Cellular Therapy. 29:324.e1-324.e6
Autor:
Ran Reshef, Hyung C. Suh, Monzr M. Al Malki, Aasiya Matin, Ashish S Kothari, Allison Bell, Antoine J Boudot, Yun Wang, Nina Abelowitz, James Murray, Gavin Macbeath, Debora Barton, Shrikanta Chattopadhyay
Publikováno v:
Blood. 140:7468-7469
Autor:
Abdul Moiz Khan, Neha Venkatesh, Joseph P. Uberti, Voravit Ratanatharathorn, Dipenkumar Modi, Lois Ayash, Asif Alavi, Andrew Kin, Aasiya Matin, Abhinav Deol
Publikováno v:
Blood. 140:7565-7566
Patients with renal cell carcinoma (RCC) often remain asymptomatic until the disease is advanced, with about 25% presenting at an advanced stage. We present a case of metastatic RCC treated with combination ipilimumab and nivolumab with complete radi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8b1c6ef316b04470ecc3c53a855e780
https://europepmc.org/articles/PMC7155964/
https://europepmc.org/articles/PMC7155964/
Publikováno v:
Blood. 138:3287-3287
Timely and effective reconstitution of the hematopoietic niche is imperative post-allogeneic stem cell transplantation (alloHCT) for prevention of life-threatening opportunistic infections and relapses. Efficient engraftment is dependent on the abili
Autor:
Allison C. Rosenthal, Thomas M. Habermann, Yucai Wang, Stephen M. Ansell, Grzegorz S. Nowakowski, Han W. Tun, James R. Cerhan, Aasiya Matin, Ivana N. Micallef, Thomas E. Witzig, Patrick B. Johnston, Aung M. Tun, David J. Inwards, Jose C. Villasboas, Jonas Paludo, Luis F. Porrata
Publikováno v:
Blood. 138:1373-1373
Introduction: Novel therapeutic agents such as immune checkpoint inhibitor (ICI) and brentuximab vedotin (BV) are active in classic Hodgkin lymphoma (cHL), including in patients that relapse after autologous stem cell transplant (ASCT). However, opti
Autor:
Akash Mukherjee, Rhonda Evans, Aasiya Matin, Haley Gass, Abhijit Godbole, Alperdis Keyes, Rachel Hendrix, Appalanaidu Sasapu, Judith Ware, Mallory Brown, Sunil Kakadia, Christina Marsh, Muthu Veeraputhiran, Denese Harris
Publikováno v:
Transplantation and Cellular Therapy. 27:S224-S225